IndraLab

Statements



eidos
"Interestingly , USP18 inhibition promotes the antibacterial effect of TNFalpha and subsequently induces reactive oxygen species ( ROS ) , thereby controlling primary and secondary bacterial infection , which suggests the therapeutic potential of targeting USP18 in patients to ameliorate disease caused by serious bacterial infections ."